Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia

Haematologica. 2009 Oct;94(10):1368-74. doi: 10.3324/haematol.2009.005918. Epub 2009 Jul 16.

Abstract

Background: Hereditary thrombocythemia is a rare disease characterized by increased megakaryopoiesis and overproduction of platelets. Germ line mutations have been identified in the genes for thrombopoietin (THPO) and its receptor, MPL. A clustering of familial cases with the MPL-G1073A mutation that results in a serine to asparagine substitution (S505N) has been recently reported in Italy. Here we performed haplotype analysis in nine families (eight Italian and one Japanese) with hereditary thrombocythemia carrying the MPL-S505N mutation in the MPL gene.

Design and methods: The MPL gene was examined by genomic DNA sequencing. Haplotype analysis was performed using microsatellites and single nucleotide polymorphisms.

Results: Analysis of microsatellite markers and single nucleotide polymorphisms in the eight Italian families with hereditary thrombocythemia revealed the presence of a common haplotype compatible with a founder effect, which may have originated 23 generations ago. This haplotype was rarely observed in 132 unrelated individuals and was absent in a Japanese family with the MPL-S505N mutation.

Conclusions: The recurrent MPL-S505N mutation found in the eight Italian families with hereditary thrombocythemia is likely due to a founder effect.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Asian People / genetics
  • Child
  • Child, Preschool
  • Evidence-Based Medicine
  • Female
  • Founder Effect*
  • Haplotypes / genetics
  • Humans
  • Infant
  • Italy
  • Male
  • Microsatellite Repeats / genetics
  • Middle Aged
  • Mutation / genetics*
  • Pedigree
  • Receptors, Thrombopoietin / genetics*
  • Thrombocytosis / genetics*
  • Thrombopoietin / genetics*
  • White People / genetics*
  • Young Adult

Substances

  • Receptors, Thrombopoietin
  • MPL protein, human
  • Thrombopoietin